Sonova (OTCMKTS:SONVY) Downgraded by Barclays to Strong Sell

Barclays cut shares of Sonova (OTCMKTS:SONVY - Free Report) from a hold rating to a strong sell rating in a research note released on Friday,Zacks.com reports.

Several other research firms also recently issued reports on SONVY. Hsbc Global Res downgraded shares of Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st. HSBC cut Sonova from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. BNP Paribas cut Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Finally, Kepler Capital Markets upgraded shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. Four analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. According to data from MarketBeat.com, Sonova currently has an average rating of "Hold".

Sonova Price Performance

OTCMKTS:SONVY traded up $1.02 during trading hours on Friday, hitting $60.44. The company's stock had a trading volume of 27,217 shares, compared to its average volume of 21,285. Sonova has a 52-week low of $52.83 and a 52-week high of $77.56. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. The stock has a fifty day moving average of $61.93 and a 200-day moving average of $63.32.

Sonova Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, July 2nd. Stockholders of record on Tuesday, June 17th will be paid a dividend of $0.6243 per share. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from Sonova's previous dividend of $0.57. This represents a dividend yield of 0.99%.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.